Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy. [electronic resource]
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Oct 2015
- 1846-1853.e1 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1542-7714
10.1016/j.cgh.2015.04.013 doi
Antiviral Agents--therapeutic use Carcinoma, Hepatocellular--epidemiology Female Hepatitis C, Chronic--complications Humans Hypertension, Portal--complications Interferon-alpha--therapeutic use Liver Failure--complications Liver Neoplasms--epidemiology Male Middle Aged Polyethylene Glycols--therapeutic use Recombinant Proteins--therapeutic use Ribavirin--therapeutic use Risk Assessment Spain Survival Analysis Treatment Outcome Viral Load